Hatice Zeynep Atlı

Dr. Hatice Zeynep Atlı

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
AKAyse Muge Karcioglu
Ayse Muge Karcioglu
HAHatice Zeynep Atlı
Hatice Zeynep Atlı
UDUgurcan Degdas
Ugurcan Degdas
Background/Objectives: Community-acquired pneumonia (CAP) is a leading cause of ICU admission and death in older adults, yet the severity scores used in this setting were not developed for, or validated in, older intensive care patients. We compared a pneumonia-specific score (SMART-COP) with the general ICU scores SOFA and APACHE II and with CURB-65 for predicting adverse outcomes in this population. Methods: In this single-center prospective observational study, 227 consecutive patients aged ≥65 years admitted to the ICU with CAP were enrolled. SMART-COP and CURB-65 were calculated at hospital admission and SOFA and APACHE II at ICU admission. The discrimination of each score for four outcomes—in-ICU mortality, need for intubation, vasopressor requirement, and hospital-acquired pneumonia (HAP)—was assessed by ROC analysis, and areas under the curve (AUCs) were compared pairwise using the DeLong test. Results: All four scores predicted mortality, intubation, and vasopressor requirement (all p ≤ 0.001), but none discriminated well for HAP (all AUCs < 0.70). SMART-COP had the highest AUCs for mortality (0.846) and intubation (0.870), significantly exceeding CURB-65 (both p < 0.01) while performing comparably to SOFA and APACHE II. SOFA was the strongest predictor of vasopressor requirement (AUC: 0.867). Conclusions: In older ICU patients with CAP, SMART-COP—calculable from routine parameters at admission—matched far more complex ICU scores for mortality and intubation and outperformed CURB-65. The optimal score depends on the outcome of interest.

16 September 2026 in Archives of Current Medical Research
Verified
Journal Article
Closed access
HAHatice Zeynep Atlı
Hatice Zeynep Atlı
MIMehmet İbIş
Mehmet İbIş
Background: Hepatitis B virus (HBV) reactivation is a critical complication for patients undergoing immunosuppressive therapy. This study aimed to evaluate the clinical outcomes of HBV screening, prophylaxis strategies, and the incidence of reactivation in patients receiving immunosuppressive regimens.Methods: We conducted a retrospective study at Gazi University Faculty of Medicine involving 90 patients with HBV infection who were candidates for immunosuppressive therapy between January 2010 and December 2017. Demographic characteristics, viral serology (HBsAg, anti-HBs, anti-HBc, HBeAg, anti-HBe, and HBV-DNA levels), types of underlying diseases, and antiviral prophylaxis protocols were analyzed. Reactivation was defined based on virological and biochemical parameters during follow-up.Results: The study included 90 patients (mean age 53.57 ± 6.3 years; 46.7% female). The primary indications for immunosuppression were oncological diseases (n=55, 61.1%), followed by rheumatologic disorders (18.9%). Among the oncology subgroup, 31 of 55 patients (56.4%) were HBsAg positive, accounting for 31 of the 49 HBsAg-positive patients in the overall cohort. Of 55 patients with adequate follow-up, HBV reactivation was detected in 5 (9.1%). Significant differences were observed in ALT and AST levels based on HBsAg positivity (p=0.036 and p=0.021, respectively). Among followed patients, no reactivation occurred in the lamivudine group (0/11), while reactivation was observed in tenofovir (2/22), entecavir (1/14), and sequential lamivudine-tenofovir groups (2/8). The highest reactivation rate was observed in patients with delayed prophylaxis initiation.Conclusions: Pre-treatment screening for HBV is essential to identify at-risk patients. Timely initiation of potent antiviral prophylaxis significantly reduces reactivation rates and associated hepatic complications in immunocompromised patients.

22 May 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
HAHatice Zeynep Atlı
Hatice Zeynep Atlı
OAOsman Yağız Atlı
Osman Yağız Atlı
AKAyse Muge Karcioglu
Ayse Muge Karcioglu
MDMerve Tokatlı Doğan
Merve Tokatlı Doğan
GAGözde Şengül Ayçiçek
Gözde Şengül Ayçiçek
YGYavuz Kutay Gökçe
Yavuz Kutay Gökçe
Objective: The primary objective was to evaluate whether admission serum albumin predicts six-month all-cause mortality in older adult patients admitted to the intensive care unit (ICU) after simple fracture surgery, and to compare its predictive performance with the modified Nutrition Risk in the Critically Ill (mNUTRIC) score and the Nutrition Risk Screening 2002 (NRS-2002). The secondary objectives were to identify baseline predictors of six-month mortality and high-risk mNUTRIC classification. Methods: This retrospective cohort study included patients aged ≥65 years admitted to the ICU of a tertiary care hospital after surgery for a simple fracture between July and December 2024. Demographic data, comorbidities, admission laboratory values (including albumin, prealbumin, and 25-hydroxy vitamin D, the latter included as an adjunctive nutritional biomarker), APACHE II, SOFA, mNUTRIC, and NRS-2002 scores were recorded. Postoperative complications and admission durations were evaluated. Binomial logistic regression models were constructed for six-month all-cause mortality and nutritional risk group classification. Receiver operating characteristic (ROC) analysis with the Youden Index was performed to determine cutoff values. Results: A total of 172 patients (mean age 80.84 ± 7.72 years; 67.4% female) were analyzed. Six-month all-cause mortality was 22.7%. Serum albumin (OR 0.823, 95% CI 0.729–0.928, p = 0.002) and ICU admission duration (OR 1.413, 95% CI 1.101–1.812, p = 0.007) were independent predictors of six-month all-cause mortality, whereas mNUTRIC, NRS-2002, and vitamin D were not. Neither mNUTRIC nor NRS-2002 scores differed significantly between survivors and non-survivors. In nutritional risk group analysis, age (OR 1.117, p = 0.001) and APACHE II (OR 1.694, p = 0.001) were independent predictors of high mNUTRIC risk. Head-to-head ROC analysis for the primary outcome of six-month all-cause mortality showed that admission serum albumin (AUC 0.698, 95% CI 0.604–0.793) provided significantly better discrimination than mNUTRIC (AUC 0.570, DeLong p = 0.046) and NRS-2002 (AUC 0.550, DeLong p = 0.039). In a sensitivity model restricted to admission-time variables (albumin, age, APACHE II, vitamin D, Charlson Comorbidity Index), admission albumin remained an independent predictor (OR 0.830, 95% CI 0.747–0.923, p < 0.001) and age emerged as a further independent predictor (OR 1.062, p = 0.034). Conclusions: Serum albumin outperformed mNUTRIC and NRS-2002 in predicting six-month all-cause mortality among older adult post-fracture ICU patients. Because neither mNUTRIC nor NRS-2002 discriminated between survivors and non-survivors, these scores alone cannot be recommended as mortality-prediction tools in this orthogeriatric ICU population. Whether admission albumin adds incremental value to existing nutritional scoring in this setting requires prospective, adequately powered validation.

20 September 2022 in Turkish Journal of Intensive Care
Verified
Journal Article
Closed access
AKAyse Muge Karcioglu
Ayse Muge Karcioglu
HAHatice Zeynep Atlı
Hatice Zeynep Atlı
OKOğuz Karcıoğlu
Oğuz Karcıoğlu
ITIşıl Ozkocak Turan
Işıl Ozkocak Turan
Amaç: Koronavirüs hastalığı-2019 (COVİD-19) pandemisi nedeniyle solunum yetmezliği gelişen hastalarda oksijen desteği için farklı cihazlar ve yöntemler kullanılmıştır. Bu yöntemlerden birisi de daha önce akut solunum yetmezliğinde faydalı olduğu gösterilen yüksek akımlı nazal kanüldür (HFNO). Bu çalışmada, COVİD-19 nedeniyle yoğun bakım ünitelerinde yatan hastalarda HFNO’nun etkinliğinin araştırılması amaçlanmıştır. Gereç ve Yöntem: COVİD-19 nedeniyle yoğun bakımda takip edilen hastalar geriye dönük olarak tarandılar. Yoğun bakım yatışı sırasında HFNO ile tedavi edilen hastalar çalışma grubunu oluşturdu. Demografik veriler, laboratuvar sonuçları, tedavi modaliteleri, komplikasyonlar ve klinik sonuçlar arasındaki ilişki incelendi. Bulgular: Dahil edilen 330 hasta arasında HFNO ile ortalama ventilasyon süresi 7,84 gündü. Yüz yetmiş (%51,5) hasta HFNO tedavisi sırasında entübe edilmişti. Bunlardan sadece 5’i ekstübe olabilmişti. Entübe edilen hastaların ortalama HFNO alma süresi [9,74 gün - minimum (min): 2, maksimum (maks): 49] entübe olmayan hastalara (6,05 gün - min: 1, maks: 30) göre daha yüksekti. Mortalite ile yaş [olasılık oranı (OR): 1,04], Akut Fizyoloji ve Kronik Sağlık Değerlendirmesi-II skoru (OR: 1,35), kanser öyküsü (OR: 3,89), non-invaziv ventilasyon uygulanması (OR: 5,94) ve sekonder bakteriyel enfeksiyon varlığı (OR: 44,6) arasında anlamlı bir ilişki vardı. Sonuç: Akut solunum yetmezliğinde faydası kanıtlanmış olan HFNO’nun, COVİD-19 hastalarında da yaygın ve başarılı bir şekilde kullanıldığı görülmüştür. HFNC kullanımının entübasyon gereksinimi ve mortalite üzerindeki etkisini göstermek için kapsamlı randomize çalışmalara ihtiyaç vardır.

11 September 2026 in BMC Emergency Medicine
Verified
Journal Article
Open access
PDF file
HAHatice Zeynep Atlı
Hatice Zeynep Atlı
ZMZaur Mehdiyev
Zaur Mehdiyev
AKAyse Muge Karcioglu
Ayse Muge Karcioglu
MSMehmet Murat Sayın
Mehmet Murat Sayın
This study evaluated clinical, laboratory, and radiological predictors of in-hospital mortality in ICU patients with acute methanol intoxication. Fifty-sev

19 May 2026 in Journal of Health Sciences and Medicine
Verified
Journal Article
Closed access
HAHatice Zeynep Atlı
Hatice Zeynep Atlı
DŞDürdane Şenol
Dürdane Şenol
TTTaşkın Tepe
Taşkın Tepe
EGEnes Gürün
Enes Gürün
RBRıfat Bozkuş
Rıfat Bozkuş
Aims: This study aimed to evaluate the knowledge and awareness of intensive care nurses regarding brain death and organ donation, and to determine the association of institutional training and clinical experience with their attitudes toward postmortem organ donation.Methods: This descriptive, cross-sectional study was conducted among 446 intensive care nurses working in a tertiary care hospital. Data were collected using a structured questionnaire consisting of four sections, including sociodemographic characteristics, knowledge and experiences related to brain death and organ donation, and the Organ Donation Attitude Scale Toward Postmortem Organ Donation. Statistical analyses were performed using appropriate parametric tests, with a significance level set at p0.05). However, nurses who attended institutional “brain death and donor care” training demonstrated significantly higher scores in the negative attitude subdimension (p=0.020), indicating more favorable attitudes after reverse scoring. Additionally, nurses with experience in following up patients diagnosed with brain death had significantly higher positive attitude and total scale scores (p=0.003 and p=0.010, respectively). No significant differences were observed based on donor care experience.Conclusion: Intensive care nurses demonstrated generally positive attitudes toward organ donation; however, a discrepancy between willingness and actual donor registration persists. Targeted institutional training and clinical exposure to brain death cases are associated with more positive attitudes. Expanding structured training programs and integrating nurses more actively into the organ donation process may improve donation rates.